Paper37463564
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
Tamma PD and 5 others. Clin Infect Dis, 2023. Cited by 620 papers, by iCite.
Cite this record
ConductScience Library. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Papers, record 37463564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37463564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07398703 | Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICU | Background |
Source ClinicalTrials.gov
Cited by430
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 620 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973857 | Clinical and microbiological determinants of treatment failure in complicated urinary tract infection: a four-hospital cohort of enterobacterales infections in Misurata, Libya. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42973857 | PubMed |
| 42953638 | Multidisciplinary Antimicrobial Stewardship Program in an Indian ICU: A Time-Series Analysis of Diagnostic Practices and Antibiotic Use. | Cureus | 2026 | https://conductscience.org/library/papers/42953638 | PubMed |
| 42938768 | Concordance Between Multiplex-PCR Resistance-Gene Detection and MIC-Based Susceptibility in Gram-Negative Clinical Isolates from a Romanian Tertiary Hospital. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42938768 | PubMed |
| 42938103 | Diagnostic and Management Challenges in Mixed-Source MDR Sepsis in a Kidney Transplant Recipient with an Infected Sacral Pressure Ulcer Treated with VAC Therapy: A Case Report. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42938103 | PubMed |
| 42921315 | Phenazine Biosynthesis Inhibitors as Pseudomonas aeruginosa Antivirulence Agents. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42921315 | PubMed |
| 42886673 | Laboratory-based surveillance of antimicrobial non-susceptibility in Enterobacter species over 12 years at a tertiary-care hospital in Saudi Arabia. | PLoS One | 2026 | https://conductscience.org/library/papers/42886673 | PubMed |
| 42825581 | Genomic characterization of carbapenem-resistant organisms from pediatric patients with hematological malignancies and genomic comparison of infection versus intestinal colonizing strains. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42825581 | PubMed |
| 42807182 | Clinical gradient and predictors for stepwise resistance escalation of carbapenem-susceptible, carbapenem-resistant, and difficult-to-treat resistant Pseudomonas aeruginosa infections: a 6-year retrospective cohort study. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42807182 | PubMed |
| 42803855 | Risk factors for recurrent urinary tract infection after SGLT2 inhibitor reinitiation in type 2 diabetes. | Endocrine | 2026 | https://conductscience.org/library/papers/42803855 | PubMed |
| 42795652 | Paired In Vitro Susceptibility of Cefiderocol and Colistin in Colistin-Resistant, Extensively Drug-Resistant Gram-Negative Bacilli: A Single-Centre, MIC-Based Analysis of 236 Clinical Isolates. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795652 | PubMed |
| 42699590 | The influence of chlorogenic acid disinfection on the oral microbiota of alginate impressions. | J Oral Microbiol | 2026 | https://conductscience.org/library/papers/42699590 | PubMed |
| 42696374 | Computed tomography-guided precision biopsy combined with metagenomic next-generation sequencing for etiological diagnosis in patients with blood culture-negative systemic infections. | J Int Med Res | 2026 | https://conductscience.org/library/papers/42696374 | PubMed |
| 42687566 | One Model to Dose Them All: A Population Pharmacokinetic Model for Multiple Aminoglycosides Across the Human Lifespan. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42687566 | PubMed |
| 42683082 | Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42683082 | PubMed |
| 42668754 | Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle. | Pak J Med Sci | 2026 | https://conductscience.org/library/papers/42668754 | PubMed |
| 42657893 | Clinical use of ampicillin-sulbactam/ceftazidime-avibactam combination therapy for carbapenem-resistant Acinetobacter baumannii complex infections. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42657893 | PubMed |
| 42654965 | Genotypic and Phenotypic Resistance Profiles of Invasive Acinetobacter baumannii Isolates at Bulgarian University Hospital. | Microorganisms | 2026 | https://conductscience.org/library/papers/42654965 | PubMed |
| 42650721 | Real-World Antibiotic Strategies for Multidrug-Resistant Pseudomonas aeruginosa: Evidence from the Italian SUSANA Multicentre Study. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42650721 | PubMed |
| 42638875 | Development and validation of an interpretable machine learning model for predicting multidrug-resistant infections in ICU patients. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42638875 | PubMed |
| 42636225 | Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study. | PLoS One | 2026 | https://conductscience.org/library/papers/42636225 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37463564
GET https://conductscience.org/api/papers/v1/37463564/cited_by?page=2